In Rwanda, 75% of women with cervical cancer don’t survive. The “One Egg-A-Day” initiative provides essential nutrition to those in treatment. Help us support these women—donate today.
GIAHC is proud to have been a part of the launch of the Mysore Consortium Against Cervical Cancer (MCACC) during the week of the centennial celebration of Mysore Medical College (Dr. Krishnan’s alma mater).
GIAHC is deeply honored to be a part of the “Quad Cancer Moonshot team,” collaborating with our partners to take bold action against #cervicalcancer in the Asia Pacific region. Together, we are committed to eliminating this disease for a healthier future.
Women in Asia are diagnosed with cervical cancer at a disproportionately higher rate than the global average. Despite early diagnosis leading to more effective treatment, many factors in the region prevent women from receiving the care that they need, and the consequences are severe, affecting not only women as individuals, but society at large.
It has been a great honor to be a part of President Biden’s Cancer Moonshot delegation to India and to participate in the US-India Cancer Dialogue Initiative.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
GIAHC is excited to announce its partnership with CAPED India. Together, they will raise awareness about HPV vaccination among parents in India and develop an educational series for healthcare providers on cervical cancer screening and early treatment.
On March 4th, GIAHC and PHRII in Mysore, India, will begin a week of HPV awareness events, highlighting the importance of vaccination and screening, culminating in a screening camp on International Women’s Day, March 8th.
GIAHC, in collaboration with Vaccine Ambassadors, is spearheading a fundraising initiative to donate 6,000 HPV vaccine doses to Suriname.
Global Initiative Against HPV and Cervical Cancer (GIAHC) has announced a partnership with The Global HPV Consortium, spearheaded by the Sabin Vaccine Institute. This collaboration aims to intensify efforts to combat Human Papilloma Virus (HPV) infections and eradicate cervical cancer as a major public health issue.